← Analysis page  ·  Horizon Kinetics hub  ·  Research hub

Actionable insights — Horizon Kinetics Q2 2026 Commentary

Not what they own but how they decide: the valuation tests, the sell arithmetic, the time-versus-price discipline and the two-method triangulation in "The Time & Compounding Edition" — extracted so each can be rerun on different names.
2026-JUL-31 · Horizon Kinetics Quarterly Commentary · Horizon Kinetics LLC · Read ↗ · full analysis · transcript
How to read this page: each insight is a repeatable method the commentary actually describes — the test, the arithmetic, the question to ask next time. The boxed line shows how it played out in this quarter's letter. Nothing here is generic advice; every step is grounded in the source text.

1. The planted-axiom test — never accept a headline multiple you haven't rebuilt

The repeatable method
  1. When you hear a valuation claim, ask what it rests on. A "planted axiom" is an unsupported assertion that makes an argument seem logical at the start, with everything after resting on a false or absent foundation ("it's pulled back from its highs and consensus estimates have bottomed out" tells you only what the price did and what others think).
  2. Rebuild the multiple on cash, not accounting earnings. Where P/E is meaningless or misleading for a business type, say why, and name the alternative measure before using it.
  3. Handle negatives honestly. Analysts normally drop negative-figure companies out of an average; instead, assign them a deliberately generous number and disclose it, so the group average is computable and the bias runs against your own conclusion.
  4. Do NOT add stock compensation back. If a company didn't issue options, employees would demand cash — so it is an operating expense, and it dilutes shareholders even in share form. Size it in dollars, not as a percentage nobody feels.
Here: the quoted bull case was a Mag 7 P/E of 24.8, "cheaper than the 29.6 of 12 months ago." Rebuilt: two of the seven have negative free cash flow and one trades at 700x; calling the two negatives an even 100x so all seven can be averaged gives 150x run-rate free cash flow, with $108 billion of run-rate stock compensation left in as the expense it is. AMZN GOOGL META NVDA.
Watch for

2. The royalty-company cycle test — buy when the commodity is below cost, sell when the premium is embedded

The repeatable method
  1. Find the moment the commodity price sits below the cash cost of production for a meaningful share of the industry. That is when producers are capital-starved and will sign away future output on terms they would never otherwise accept — high double-digit implied financing rates on 20-year, life-of-mine contracts on world-class assets.
  2. Underwrite the purchase as a business valuation selection, not a commodity price wager: the contract discount rate, free exploration optionality on the surrounding land package, insulation from operating costs and balance-sheet risk. If the commodity also rallies, that is upside you did not need.
  3. Track the bookend condition. When the commodity is comfortably above all-in sustaining cost, producers regain capital access and the royalty company can no longer sign contracts with the same earnings power or optionality. The reason you bought has expired even though the business has not deteriorated.
  4. Name the model's real limits before defending it: no discretion over mine operations, and no pricing power — royalty companies are price takers on the metal.
Here: bought after gold fell from ~$1,900 (2011) to under ~$1,100 (2015), below cash cost for much of the sector. Sold/reduced WPM and FNV now that gold has run to $5,400 and back to ~$4,100 — "these higher gold prices are now embedded as premiums in the current valuations… much as the depressed gold prices a decade earlier were embedded as discounts."
Watch for The repeatable method
  1. Open up the consensus net asset value. Three inputs decide it: the assumed commodity price path (typically today's price fading modestly), which production is counted (usually only producing or imminent mines — non-producing royalties are valued at zero), and the discount rate.
  2. Convert the discount rate into a multiple you can feel. A 3%–5% discount rate on decades of cash flow is the equivalent of paying a 20x to 33x P/E. Compare it to the rate the company itself negotiates in its own deals — if the market discounts at 3% what management underwrites at 15%, you are on the wrong side of that spread.
  3. Concede what the NAV misses in the other direction (perpetual gold optionality, exploration upside, future deals) — which is why such a company should trade above NAV. The question is never premium-or-not; it is how large a premium.
  4. Then run the compression case, holding the business perfect: earnings growing 15%/yr for 15 years, but the multiple sliding from 2x NAV to 1.5x NAV over five years. If the answer is a single-digit return, the position is a sale on arithmetic alone.
Here: $100,000/yr for 20 years discounted at 15% = ~$625,000 — buying $2 million of future payments for ~30¢ on the dollar. At 3%, the same $2 million costs almost $1.5 million. And 2x NAV → 1.5x NAV over five years turns a 15% compounder into an 8.6% annualized return — "a valuation contraction within that time frame overwhelms the gradual accumulation of compounded growth."
Watch for

4. Watch TIME, not price — the drawdown-fractal check before you conclude "this time is different"

The repeatable method
  1. When a long-term holding is deeply off its high and the discomfort is "it's never been down this long," go and look it up. Pull the full price history and count the prior drawdowns by depth and duration.
  2. Magnify an earlier window of the same chart. The smooth-looking early years are a mirage produced by compounding on a linear axis; blow them up and the volatility is identical — the pattern is fractal.
  3. Ask what actually changed in the business model and the valuation. Absent those, "short-term price behavior offers no predictive information, and using price as a decision-making tool is likely to lead to the wrong long-term outcomes."
  4. Understand why this is hard: brains built for the veldt spot sudden pattern changes and linear pursuit well, and handle geometric functions and long time frames badly. Under a power law, value arrives disproportionately at the very end of the interval — so the correct thing to monitor is elapsed time, not the balance.
Here: TPL was 30% off its high and a client (himself a fund manager) said the pain had lasted longer than ever. The record: four separate 40–53% declines in eight years, and a ~75% decline over a year fifteen years ago — with the shares up 4-fold from that eight-year-ago high. The "other" chart in the exercise, down 66% over a year and change, was ICE. The water glass is 50% full one time step from the end; the snowball has 15% of its mass at half the clock.
Watch for

5. The switching-cost test — price the tax and the years before trading good for better

The repeatable method
  1. Before selling an appreciated compounder for a better idea, compute the reinvestment haircut: after gains taxes you redeploy roughly 85¢ on the dollar.
  2. Assume you are right — the new holding really does grow 25% faster — and solve for the break-even year. In the commentary's illustration that is year seven.
  3. Now ask the real question: will you actually hold the replacement for seven years to find out? "It takes a lot of time to develop excess value through growth."
  4. Apply the temperament filters: "the hardest temptation to resist is to trade something good for something average" (Peter Doyle), and "patient inactivity is hard, demanding, and exhausting work" (Murray Stahl).
Here: the sell-at-the-high table, offered as the standing answer to the perennial "why haven't you sold?" and "isn't it time to sell?" client questions — one of many risks and costs entailed in breaking a compounding chain for a presumably repeatable trading tactic.
Watch for

6. The ETF Divide screen — hunt where index mechanics impose a non-economic discount

The repeatable method
  1. Screen for the shapes index organizers structurally cannot buy: market caps below the smallest index constituents; companies shrinking their own float through buybacks; heavy insider or parent-company ownership that collapses the float-adjusted cap; conglomerates whose best asset sits inside a "wrong" industry designation; illiquid names an institution could neither build nor exit quickly.
  2. Separate the two discount sources and name which one you are being paid for: the Equity Yield Curve (value realization too distant or indeterminate for a relative-return industry) and the ETF Divide (discounts imposed for non-economic, non-fundamental reasons).
  3. Verify the fundamental record independently — long-run per-share earnings growth, margins, the buyback's actual share-count effect (retiring 2.5% of total shares is 7.5% of the traded float when insiders hold two-thirds).
  4. Then honestly test for NFL risk (No Free Lunch risk): is the market pricing a real risk you are dismissing? If not — and the discount traces to flows, coverage and liquidity rules — the lunch is free.
Here: AN — 13.7%/yr per-share earnings growth since 2000 at 11x, having repurchased 58% of shares in five years. PAG — 14% 15-year EPS growth at 11x, with >50% insider ownership plus 20% at Mitsui making an $11B cap a ~$3B float (and, days later, a take-private offer for the remaining 17%). Both are smaller than the two smallest S&P 500 members, which carry 0.1% and 0.0% weights. Plus the unnamed Asian airport: a fast-growing subsidiary of a several-billion-dollar parent, at a discount to book and single-digit cash earnings, against ~25x EBITDA for comparable listed airports.
Watch for

7. Separate the perpetuity from the depletable asset — then measure it per share

The repeatable method
  1. Inside any resource company, split the balance sheet in two: the perpetuity (surface acreage, which can be repurposed to higher uses and compounds forever) and the depletable minerals that came with it. They deserve different valuation multiples, and management that understands the difference can create value by trading one for the other.
  2. Judge the company on units of the perpetuity per share, not on total growth. Acreage can triple while acres per share falls if it was bought with stock.
  3. Prefer a land position large enough that cash flow does not have to be reinvested to stand still — that is what frees the budget for dividends, buybacks and opportunistic expansion.
  4. Check management's own cash commitment, distinct from granted equity: a requirement to purchase stock worth a multiple of salary within a fixed window is evidence the team expects to be present for the long compounding stretch.
Here: PSK.TO tripled acreage from 5 million to 18 million acres over 12 years and doubled acres per share — ~6%/yr of per-share land accretion before any revenue growth — across a 750-mile position in three provinces, with executives required to buy 2x–5x salary in stock with cash within three years. The original TPL recommendation 30-plus years ago used the same logic: buy the land, not the oil, and let buybacks raise per-share acres. Land is not even a sector in the equity indexes, and acres-per-person only shrinks.
Watch for

8. Underwrite the growth that needs no capital

The repeatable method
  1. Isolate revenue growth that arrives with zero capital spending and no management effort, and quantify it separately from discretionary growth. Two sources qualify: a physical/geological trend in volumes, and contractual inflation escalators.
  2. Model the physical trend explicitly (ratio today → ratio in N years → implied annualized volume growth), and state what it does not depend on — customer expansion, new projects, commodity price.
  3. Add the contract escalators from a published index to get a floor revenue growth rate; treat repricing of new contracts above the current rate as separate upside.
  4. Then value the optionality on top as a call, not as a base case (new use classes for the same asset that generate recurring, high-margin, royalty-like revenue).
Here: LB — Delaware Basin wells lift ~4 barrels of brackish water per barrel of oil today, an estimated 6-to-1 by 2030 (≈9% annualized volume growth) purely from an ancient inland sea's hydrogeology, before any output expansion by the majors. Ten-year water contracts carry CPI escalators, giving "12% or greater revenue growth, which requires no capital spending" — with pore-space repricing above ~$0.11/barrel, aquifer source water at ~$1/barrel, and "powered land" (data centers, roads, power lines, wind, solar, carbon capture) as the option.
Watch for

9. The commercial-utility test — decide whether a new product is a threat before the tape does

The repeatable method
  1. When a headline says a new venue or instrument threatens an incumbent, first separate the shares going down from the business going down. Check the latest reported revenue, operating margin and per-share earnings, and the incremental margin on new volume.
  2. Ask what economic need the new product serves. A hedging instrument requires an expiry date, delivery of the underlying, and an exchange enforcing collateral on both sides — that is what lets a commercial user offset a real exposure.
  3. If the instrument lacks expiry and delivery, it cannot hedge a business commitment; it is a leveraged wager (gamification) competing for retail speculators, not for the institutional flow that is most of the incumbent's revenue. Size the customer mix to prove it.
  4. Ask the reverse question: can the incumbent simply offer the new product? If nothing precludes it — and the incumbents are already launching versions — the "threat" is a demonstration of demand, i.e. an expansion of the incumbent's addressable market.
  5. Finally, check the historical pattern: has this industry converted crises and technological shifts into new products before?
Here: the May 15–June 22 lockstep 22–38% decline across ICE CME CBOE MIAX on Hyperliquid/perpetuals and Kalshi headlines — while ICE's FY2025 revenue +6% produced double-digit EPS growth at a 33% after-tax margin and MIAX grew revenue 40% with 2x free cash flow. ICE has had no futures contract failure in nearly 30 years; 85–90% of its business is institutional. Kalshi and Polymarket are read as "an indicator of extraordinary next-generation, next-decade expansion possibilities," and the Middle East's new oil export routes will require new hedging contracts the exchanges will compete to list. Outcome: ICE and CME at their cheapest valuations in 17 years.
Watch for

10. Triangulate a price with two unrelated methods — a supply floor and a demand curve

The repeatable method
  1. Build the supply-side floor bottom-up: identify the dominant input cost (here electricity, ~60% of the total), construct a network-wide consumption schedule, divide by known network output to get average fleet efficiency, then divide by units produced per day to get cost per unit. Sanity-check by flexing the inputs (±$0.01/kWh, 55% vs 60% cost share) rather than presenting a single number.
  2. Project the floor forward through the known schedule change, and add the empirical premium producers have historically required to keep operating (they could do something else for a living).
  3. Build the demand-side curve from an independent first principle — here Metcalfe's Law (network value ∝ users², a t^2 function) combined with network size expansion (t^3, the snowball's cubic volume), giving a power function a touch under t^6.
  4. Backtest the demand curve against realized prices over the full history before using it forward, and report the misses.
  5. Only act on the convergence. Two methodologies with nothing in common landing in the same range is the signal; either one alone is a model.
Here: Bitcoin — all-in production cost ~$65,000 today at $0.05/kWh, doubling to ~$130,000 at the April 15, 2028 halving; at the typical ~75% post-halving premium, ~$225,000 (range $150k–$250k; newest rigs imply $117k–$149k today at a 25% miner ROIC). Independently, the sub-t^6 power law implies $270,438.05. Backtest: $1 in 2011 projected to $9,986 by Dec 16, 2019 vs 9,169x actual; 99,878x projected vs 110,726x actual at Apr 5, 2025.
Watch for

Methods distilled from the public Horizon Kinetics 2nd Quarter 2026 Market Commentary (full text in transcript.txt). Not investment advice. Source material © 2026 Horizon Kinetics LLC.